Grant Success! Bladder Cancer
The Urological Oncology group have recently been awarded a small grant from Action Bladder Cancer UK for £9,311.00 to help fund our project: Urinary microbiome as a predictor of response to Bacillus Calmette-Guerin (BCG) immunotherapy in non-muscle invasive bladder cancer. This project will be carried out by Dr Nicola Annel’s PhD student, Tyler Wooldridge, in collaboration with Matt Perry and Hugh Mostafid, Urology Consultants at the Royal Surrey County Hospital .
Picture caption: The team: Back row left to right: Mr Matthew Perry – Consultant Urological Surgeon,
Gregory Nason – Senior Clinical Fellow, and Mr Hugh Mostafid – Consultant Urological Surgeon. Front row left to right: Tyler Wooldridge – PhD student, and Dr Nicola Annels – Senior Research Fellow.
– PROJECT SUMMARY –
Action Bladder Cancer UK, Bacillus Calmette-Guerin immunotherapy, BCG, Bladder cancer, Dr Nicola Annels, grant, Gregory Nason, Mr Hugh Mostafid, Mr Matthew Perry, research, Royal Surrey County Hospital, Tyler Wooldridge, Urinary microbiome